v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (18,128) $ (19,271)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 2,415 3,085
Change in fair value of warrant liabilities (383) (905)
Stock compensation expense 1,222 1,615
Provision for expected credit losses 30 13
Deferred income taxes 8 12
Inventory write-down 318 809
Interest expense, related party 1,417 0
Other, net (33) (199)
Changes in current assets and liabilities:    
Accounts receivable, net 215 239
Accounts receivable from related party 584 399
Inventories 698 (2,358)
Other current assets 185 (155)
Accounts payable and accrued liabilities (2,443) (6,396)
Accounts payable to related party 901 5,622
Net cash used by operating activities (12,994) (17,490)
Cash flows from investing activities:    
Capital expenditures (688) (613)
Net cash used by investing activities (688) (613)
Cash flows from financing activities:    
Payment of borrowings under term loan - related party (Note 11) (800) 0
Repurchase of common stock (807) (250)
Net cash used by financing activities (1,607) (250)
Effect of exchange rate changes on cash and cash equivalents 7 138
Net decrease in cash and cash equivalents (15,282) (18,215)
Cash and cash equivalents:    
Cash and cash equivalents—beginning of period 82,777 64,437
Net decrease in cash and cash equivalents (15,282) (18,215)
Cash and cash equivalents—end of period $ 67,495 $ 46,222